Currently in progress, this project to aims to attract significant amounts of growth equity capital for lower mid-market corporates across multiple European countries.
There is a strong ESG and impact investment angle, with a significant focus on tech and life sciences venture capital. Investors are required to allocate through fund and co-investment structures.